Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Best Research Peptides for ADHD Research: Mechanism Comparison

Semax Increases dopamine/norepinephrine turnover via BDNF-mediated tyrosine hydroxylase upregulation Intranasal 0.1–0.3% solution, 2–3 drops per nostril twice daily 7–14 days for measurable attentional improvements Best-suited for primary attention and impulse

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Semax
  • Increases dopamine/norepinephrine turnover via BDNF-mediated tyrosine hydroxylase upregulation
  • Intranasal
  • 0.1–0.3% solution, 2–3 drops per nostril twice daily
  • 7–14 days for measurable attentional improvements
  • Best-suited for primary attention and impulse control deficits. Addresses catecholamine dysregulation without stimulant side effects
  • Selank
  • Upregulates GABA-A receptor density; modulates serotonin metabolism
  • 0.15% solution, 2–3 drops per nostril twice daily
  • 5–10 days for anxiety reduction; 10–14 days for attentional effects
  • Ideal for ADHD with comorbid anxiety. Enhances inhibitory control and reduces anxiety-driven distractibility
  • Cerebrolysin
  • Mimics neurotrophic factor activity (NGF, BDNF, CNTF); promotes dendritic growth
  • Intramuscular injection
  • 5–30ml per session, 3×/week for 4–6 weeks
  • 3–4 weeks for structural changes; cognitive effects emerge gradually
  • Targets structural neuroplasticity. Best for long-term intervention addressing grey matter deficits, not acute symptom management
  • P-21 (Pinealon)
  • Enhances norepinephrine synthesis in locus coeruleus
  • Subcutaneous injection
  • 100–200mcg daily
  • 7–10 days
  • Selective for arousal and working memory systems. Particularly effective in high-impulsivity phenotypes
  • Dihexa
  • Potentiates hepatocyte growth factor signaling; enhances synaptic plasticity
  • Oral (in research models)
  • 0.5–2mg/kg in preclinical studies
  • 2–3 weeks for cognitive enhancement
  • Promising for learning and memory deficits. Not yet tested in ADHD-specific populations